DexCom, Inc. (DXCM) Stock Analysis
Last updated Sep 8, 2026
Health Check
Last analyzed Sep 7, 2026
- Financial Health 85
- Profitability 75
- Business Quality 75
- Balance Sheet 65
- Cash Flow 80
Why this rating?
Health 76/100 — Elite Quality
Entry timing is weak right now. Quality may be fine; the setup is not.
Company overview
DexCom, Inc. (DXCM) is a Medical Devices company in the Healthcare sector. Compound Radar rates DexCom, Inc. 76/100 (Elite Quality) due to high business quality, steady revenue growth, and manageable leverage.
Investment profile
- Quality High
- Growth Moderate
- Balance Sheet Adequate
- Valuation Fair
Financial highlights
Valuation
- P/E 33.41
- Forward P/E 27.06
- PEG 1.35
- EV/Revenue 6.57
Profitability
- Revenue Growth 13.1%
- Gross Margin 62.5%
- Operating Margin 24.3%
- Net Margin 20.1%
- ROE 38.5%
Financial strength
- Cash $1.95B
- Debt $1.40B
- Net Cash $548.60M
- Free Cash Flow $1.08B
- Current Ratio 1.73
Similar companies
Peers in Medical Devices, ranked by Financial Health.
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- Globus Medical, Inc. Medical Devices GMED$75.04 82 Health 82 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Good Entry Good EntryA usable setup — not as clean as Strong Entry, but timing is not mixed or weak.
- Boston Scientific Corporation Medical Devices BSX$44.98 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Edwards Lifesciences Corporation Medical Devices EW$86.72 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Insulet Corporation Medical Devices PODD$142.28 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- TransMedics Group, Inc. Medical Devices TMDX$88.27 77 Health 77 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Haemonetics Corporation Medical Devices HAE$102.84 74 Health 74 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Inspire Medical Systems, Inc. Medical Devices INSP$62.14 73 Health 73 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Stryker Corporation Medical Devices SYK$276.43 71 Health 71 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar scores and tracks DexCom, Inc. (DXCM).